Angiomax Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Safety and Efficacy of Delayed Continuous Use of Bivalirudin 4 Hours After ePCI (COBER Study)
Condition:   Coronary Heart Disease Interventions:   Drug: delayed continuous use of bivalirudin;   Drug: bivalirudin use during ePCI Sponsor:   Nanjing First Hospital, Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2019 Category: Research Source Type: clinical trials

Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.
Conditions:   Acute Coronary Syndrome;   Percutaneous Coronary Intervention;   Aging;   Anticoagulants and Bleeding Disorders Interventions:   Drug: Bivalirudin;   Drug: Heparin Sponsors:   The First Affiliated Hospital of Dalian Medical University;   Beijing Friendship Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 6, 2019 Category: Research Source Type: clinical trials